Cerus Corporation ( CERS) - Stock Earnings
CERS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
CERS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.2 million USD | 57.8 million USD |
| 2026Q1 | -1.6 million USD | 53.7 million USD |
| 2026Q2 | -2.9 million USD | 57.4 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CERS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -37.5 million USD | 156.4 million USD |
| 2024 | -20.9 million USD | 180.3 million USD |
| 2025 | -15.6 million USD | 206.1 million USD |
| 2026 Est. | — | — |
CERS
Price: $2.28
52 week price:
Earnings Per Share: -0.03 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 1.8 million
Ebitda: -11.8 millionMarket Capitalization: 471.6 million